Paul V. Majkowski focuses on complex mass toxic tort and class action litigation in both domestic and foreign forums.

Paul’s practice includes defending claims for personal injury and property damage purportedly arising out of alleged exposure to herbicides, pesticides, and other chemicals. He is experienced in alleged dioxin exposure cases, and routinely engages with epidemiologists, toxicologists, and biostatisticians, as well as medical clinicians and scientists in other disciplines.

In addition to his focus on toxic tort and product liability, Paul successfully has litigated and arbitrated a broad range of other disputes over the course of his more than 20 years in practice. His experience includes comprehensive environmental and mass tort insurance coverage actions, employment discrimination defense, high-exposure personal injury cases, and other insurance coverage matters, including nursing home coverage.

Paul is a co-chair of the Environmental & Toxic Torts Subcommittee of the American Bar Association Litigation Section’s Mass Tort Committee. He has published and presented on a variety of issues involving mass torts, toxic torts and related science, international toxic tort litigation, and the recognition of foreign judgments, and co-chaired past ABA Chemical and Industrial Products workshops.  Paul is a member of the Adjunct Board of Instructors of the US-Korea Law Foundation and has presented at their U.S.-Korea Law Day conferences.

A former editor-in-chief of the St. John’s Law Review, Paul has served as an officer and director in the Nassau and Manhattan chapters of the law school’s alumni association. He also assists as a mentor for both St. John’s Law School and his undergraduate alma mater, New York University, and participates in the ABA’s National Appellate Advocacy Competition as a moot court judge and brief grader.

Paul devotes significant time to the Lymphoma Research Foundation. He currently serves as LRF’s Northeast Regional Leadership Council Chair, and is a past president of the Foundation’s New York City chapter and a co-founder of the Long Island chapter. Paul was named the 2016 recipient of the Lymphoma Research Foundation’s Distinguished Service Award. He also currently serves an appointment as an FDA Patient Representative through the Office of Special Health Issues and has sat on the FDA Oncologic Drug Advisory Committee.  Paul volunteers pro bono with the Cancer Advocacy Project of the New York City Bar Association.